Brown & Brown, Inc. (BRO)

FairStock Score: 74/100 — STEADY

Key Financials

Strengths

• Strong free cash flow generation of $1.4B provides financial flexibility and acquisition capacity
• Recurring revenue model from insurance broking with high customer retention rates
• Solid Q4 2025 profitability with 16.71% net margins demonstrates operational efficiency
• Low beta of 0.80 indicates defensive characteristics relative to broader market
• Diversified geographic presence across US, UK, and international markets

Concerns

• Extreme valuation disconnect: $73.50 price vs $25.60 Graham Number represents 187% overvaluation
• Dangerously low Altman Z-Score of 1.29 signals financial distress risk, particularly given 0.63 D/E ratio
• Dismal return on capital: ROCE of 4.24% and ROE of 11.23% insufficient to justify premium valuations
• Piotroski F-Score of only 6/9 indicates deteriorating financial quality and operational metrics
• Acquisition-driven growth strategy with high leverage raises sustainability concerns

AI Analysis

Brown & Brown presents a classic insurance brokerage with decent business fundamentals, but I'm cautious about the valuation. The company generates solid free cash flow of $1.4B annually and maintains a respectable 16.71% net margin in Q4 2025, suggesting operational efficiency in a recurring-revenue business. However, the financial metrics trouble me significantly. Trading at 21.22x earnings with a Graham Number of just $25.60 reveals a margin of safety of -187%—we're paying nearly three times what conservative valuation suggests. The EV/EBITDA of 56.62x is extraordinarily expensive for a service business that shouldn't command such premium multiples. The Piotroski F-Score of 6/9 indicates moderate financial health, while the Altman Z-Score of 1.29 raises bankruptcy concerns—this is dangerously close to distress territory. Most troubling: ROCE of only 4.24% and ROE of 11.23% are mediocre returns on capital in a business that should generate superior returns to justify acquisition premiums. The low FCF yield of 1.7% further confirms the price is stretched. Yes, insurance brokerages enjoy recurring revenue and modest competitive moats, but BRO's recent acquisition-driven growth and high leverage (0.63 D/E) suggest management is buying growth rather than building it organically. The 52-week range from $65.68 to $125.68 shows extreme volatility—we've already seen significant declines from peaks. I'd rather wait for a 40-50% pullback before considering this franchise.

Bull Case

Brown & Brown operates in the resilient insurance brokerage sector with inherent pricing power and recurring revenue, supported by a large employee base of 22,888 professionals generating strong $1.4B annual free cash flow. If the company can improve ROCE through operational integration and margin expansion, the compounding machine could justify current valuations, particularly given the defensive nature of insurance services during economic cycles.

Bear Case

The precarious Z-Score of 1.29 combined with 56.62x EV/EBITDA multiples and deteriorating financial quality metrics suggest the market has priced in perfection that may not materialize. Any economic slowdown affecting commercial insurance demand, coupled with integration challenges from aggressive acquisitions, could force significant earnings reductions and valuation compression.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer